Three Ebola vaccines in development amid growing outbreak fears

• Three organisations (IAVI, Moderna, and University of Oxford) are developing new Ebola vaccines in response to escalating outbreak concerns
• These vaccine development efforts represent important progress in pandemic preparedness for a virus with high mortality rates
• Multiple parallel vaccine development programmes may accelerate availability and provide alternative options for outbreak response strategies

IAVI, Moderna and the University of Oxford are all working on new vaccines.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.